Companies: 10,795·Total market cap: $144.5T
Orchard Therapeutics plc

Orchard Therapeutics plc

ORTXNASDAQHealthcare
$16.70
+$0.05(+0.30%)
Market Cap$380108700
P/E Ratio
52W High$16.72
52W Low$4.24
Overview

Orchard Therapeutics plc(ORTX)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

ortx · 股价预测 · 10 位分析师(近3月)· FMP · 更新于 2024年5月1日

分析师评级与共识

基于过去 3 个月内 10 位华尔街分析师

SellBuy

Buy

10 位分析师

共识

评级分布

Strong Buy
0
Buy
6
Hold
3
Sell
1
Strong Sell
0
合计: 10 · 买入占比: 60.0%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $16.70

Orchard Therapeutics plc(ORTX)的分析师共识为 Buy,基于过去 3 个月内 10 位华尔街分析师的评级。ORTX 的 12 个月平均目标价为 $0.00,相对当前价 $16.70 代表 +0.0% 的潜在上行空间。

短期股价预测

⚠️ 短期模型暂不可用——近期成交量过低,信号不可靠。

长期股价预测

⚠️ 长期模型暂不可用——成交量过低,信号不可靠。

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

BULLISH

Based on 14 technical indicators

57%36%7%
8Buy
5Neutral
1Sell
RSI (14)100.0Overbought
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · ORTX · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$16.70NEUTRAL
MA 10$16.70BUY
MA 20$16.58BUY
MA 50$16.43BUY
MA 100$0.00NEUTRAL
MA 200$0.00NEUTRAL
Current $ORTX · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$16.70BUY
EMA 10$16.67BUY
EMA 20$16.60BUY
EMA 50$16.43BUY
EMA 100$0.00NEUTRAL
EMA 200$0.00NEUTRAL
Current $ORTX · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
Stifel2023-10-05
Downgrade ↓
BuyHold
Stifel2023-10-04
Downgrade ↓
BuyHold
Oppenheimer2023-08-09
Maintains
OutperformOutperform
Oppenheimer2023-08-08
Maintains
OutperformOutperform
Cantor Fitzgerald2023-06-27
Maintains
OverweightOverweight
Cantor Fitzgerald2023-06-26
Maintains
OverweightOverweight
Oppenheimer2023-06-13
Maintains
OutperformOutperform
Oppenheimer2023-06-12
Maintains
OutperformOutperform
Cantor Fitzgerald2023-03-28
Maintains
OverweightOverweight
Cantor Fitzgerald2023-03-27
Maintains
OverweightOverweight

Wall Street analysts have recently issued updated ratings on Orchard Therapeutics plc (ORTX) stock. Of the recent 27 rating actions, 1 were upgrades and 7 were downgrades. 10 analysts currently cover ORTX.

分析师推荐趋势

Buy ratings101
Hold ratings02↑ +2
Sell ratings00

ORTX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$8M

↓ 63.8% YoY

Revenue Next Year

$21M

↑ 169.1% YoY

EPS This Year

$-12.10

EPS Next Year

$-5.80

↓ 52.1% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast ORTX EPS of $-12.10 for the current fiscal year, based on estimates from 0 analysts. The ORTX revenue forecast is $8M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

ORTX 股价预测由两类独立数据源支撑:来自 10 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。ORTX 的共识目标价为 $0.00(+0.0% 上行空间),分析师共识为 Buy。

Orchard Therapeutics plc 在 NASDAQ 上市,代码 ORTX。ORTX 在 2027 年的整体展望偏积极,在覆盖分析师中约 60% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

ORTX 预测 · 8 个问题

根据 10 位华尔街分析师,ORTX 的 12 个月平均目标价为 $0.00,最高 $0.00、最低 $0.00。若有图表,中位目标价可在上方查看。相对当前价 $16.70,隐含约 +0.0% 的上行空间。

ORTX 目标价ORTX 分析师目标价ORTX 12个月目标价目标价 ORTX

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.